Etrasimod: A Sphingosine-1-Phosphate Receptor Modulator for the Treatment of Ulcerative Colitis.

David K ChoiMichelle BeckerMarina IvanovShubha Bhat

Published in: The Annals of pharmacotherapy (2024)

Etrasimod is another possibility in the armamentarium of UC treatment, providing patients with more oral medication options. Prior to treatment initiation, several assessments relating to safety, drug interactions, and pharmacogenomics factors are advised.

Keyphrases

healthcare
ulcerative colitis
emergency department
combination therapy
replacement therapy
smoking cessation